Reports for BREVIBLOC PREMIXED INJECTION
Brand name
BREVIBLOC PREMIXED INJECTION
Company Name
BAXTER CORPORATION
|
Drug Identification Number
02309238 |
Ingredients
ESMOLOL HYDROCHLORIDE |
Ingredient Strength
10 MG |
ATC Code
C07AB |
ATC Descriptor
BETA BLOCKING AGENTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| BREVIBLOC PREMIXED INJECTION | 250mL Intravia Container | Resolved | 2017-07-31 | 2017-08-09 | 17549 |
| BREVIBLOC PREMIXED INJECTION | 250 mL Intravia Container | Resolved | 2019-08-16 | 2019-09-17 | 91707 |
| BREVIBLOC PREMIXED INJECTION | 10 units/case (CA2J1415) | Resolved | 2019-12-17 | 2020-01-03 | 101500 |
| BREVIBLOC PREMIXED INJECTION | 250mL | Resolved | 2023-05-23 | 2023-06-29 | 192906 |
| BREVIBLOC PREMIXED INJECTION | 250mL (CA2J1415) | Resolved | 2024-10-24 | 2025-03-13 | 241095 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0